Home/Filings/4/0001415889-25-004529
4//SEC Filing

Kiener Peter A 4

Accession 0001415889-25-004529

CIK 0001840748other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 8:15 PM ET

Size

5.5 KB

Accession

0001415889-25-004529

Insider Transaction Report

Form 4
Period: 2025-02-13
Transactions
  • Award

    Common Shares (Right to Buy)

    2025-02-13+33,39033,390 total
    Exercise: $0.93Exp: 2035-02-12Common Shares (33,390 underlying)
Footnotes (1)
  • [F1]100% of the shares underlying the option will vest on February 13, 2026, provided the Reporting Person remains in a service relationship with the Issuer or a subsidiary of the Issuer on such vesting date.

Issuer

LAVA Therapeutics NV

CIK 0001840748

Entity typeother

Related Parties

1
  • filerCIK 0001328146

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 8:15 PM ET
Size
5.5 KB